The emerging role of immune checkpoint inhibition in malignant lymphoma von Hude, Ida, Sasse, Stephanie, Engert, Andreas, Bröckelmann, Paul J

Volltext

Early Response to First-Line Anti-PD-1 Treatment in Hodgkin Lymphoma: A PET-Based Analysis from the Prospective, Randomized Phase II NIVAHL Trial von Voltin, Conrad-Amadeus, Mettler, Jasmin, van Heek, Lutz, Goergen, Helen, Müller, Horst, Baues, Christian, Keller, Ulrich, Meissner, Julia, Trautmann-Grill, Karolin, Kerkhoff, Andrea, Fuchs, Michael, Sasse, Stephanie, von Tresckow, Bastian, Dietlein, Markus, Borchmann, Peter, Engert, Andreas, Kobe, Carsten, Bröckelmann, Paul J

Volltext

Reverted exhaustion phenotype of circulating lymphocytes as immune correlate of anti-PD1 first-line treatment in Hodgkin lymphoma von Garcia-Marquez, Maria A., Thelen, Martin, Reinke, Sarah, Keller, Diandra, Wennhold, Kerstin, Lehmann, Jonas, Veldman, Johanna, Borchmann, Sven, Rosenwald, Andreas, Sasse, Stephanie, Diepstra, Arjan, Borchmann, Peter, Engert, Andreas, Klapper, Wolfram, von Bergwelt-Baildon, Michael, Bröckelmann, Paul J., Schlößer, Hans A.

Volltext

Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review von Piechotta, Vanessa, Mellinghoff, Sibylle C., Hirsch, Caroline, Brinkmann, Alice, Iannizzi, Claire, Kreuzberger, Nina, Adams, Anne, Monsef, Ina, Stemler, Jannik, Cornely, Oliver A., Bröckelmann, Paul J., Skoetz, Nicole

Volltext

LYN kinase programs stromal fibroblasts to facilitate leukemic survival via regulation of c-JUN and THBS1 von vom Stein, Alexander F., Rebollido-Rios, Rocio, Lukas, Anna, Koch, Maximilian, von Lom, Anton, Reinartz, Sebastian, Bachurski, Daniel, Rose, France, Bozek, Katarzyna, Abdallah, Ali T., Kohlhas, Viktoria, Saggau, Julia, Zölzer, Rebekka, Zhao, Yue, Bruns, Christiane, Bröckelmann, Paul J., Lohneis, Philipp, Büttner, Reinhard, Häupl, Björn, Oellerich, Thomas, Nguyen, Phuong-Hien, Hallek, Michael

Volltext

Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from the pivotal phase 2 CheckMate 205 study von Ansell, Stephen M., Bröckelmann, Paul J., von Keudell, Gottfried, Lee, Hun Ju, Santoro, Armando, Zinzani, Pier Luigi, Collins, Graham P., Cohen, Jonathon B., de Boer, Jan Paul, Kuruvilla, John, Savage, Kerry J., Trněný, Marek, Provencio, Mariano, Jäger, Ulrich, Willenbacher, Wolfgang, Wen, Rachael, Akyol, Alev, Mikita-Geoffroy, Joanna, Shipp, Margaret A., Engert, Andreas, Armand, Philippe

Volltext

Considerations for anti-PD1-based first-line treatment of Hodgkin lymphoma von Bröckelmann, Paul J

Volltext

AXL-erating mantle cell lymphoma treatment von Bröckelmann, Paul J.

Volltext

Targeting DNA Repair, Cell Cycle, and Tumor Microenvironment in B Cell Lymphoma von Bröckelmann, Paul J, de Jong, Mathilde R W, Jachimowicz, Ron D

Volltext

Case Report: Clinical Management of a Patient With Metastatic Non-Small Cell Lung Cancer Newly Receiving Immune Checkpoint Inhibition During Symptomatic COVID-19 von Mellinghoff, Sibylle C, Vanshylla, Kanika, Dahlke, Christine, Addo, Marylyn M, Cornely, Oliver A, Klein, Florian, Persigehl, Thorsten, Rybniker, Jan, Gruell, Henning, Bröckelmann, Paul J

Volltext

Unfolding the potential of anti‐programmed cell death protein 1 blockade in Hodgkin lymphoma – combination and personalisation? von Bröckelmann, Paul J.

Volltext

Case Report: Sudden very late-onset near fatal PD1 inhibitor-associated myocarditis with out-of-hospital cardiac arrest after >2.5 years of pembrolizumab treatment von Lewis, Richard I, Seuthe, Katharina, Lennartz, Simon, Weber, Jan-Phillip, Kreuzberg, Nicole, Klingel, Karin, Bröckelmann, Paul J

Volltext

Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition - A Descriptive Observational Retrospective Multicenter Analysis von Zaremba, Anne, Kramer, Rafaela, De Temple, Viola, Bertram, Stefanie, Salzmann, Martin, Gesierich, Anja, Reinhardt, Lydia, Baroudjian, Barouyr, Sachse, Michael M, Mechtersheimer, Gunhild, Johnson, Douglas B, Weppler, Alison M, Spain, Lavinia, Loquai, Carmen, Dudda, Milena, Pföhler, Claudia, Hepner, Adriana, Long, Georgina V, Menzies, Alexander M, Carlino, Matteo S, Lebbé, Céleste, Enokida, Tomohiro, Tahara, Makoto, Bröckelmann, Paul J, Eigentler, Thomas, Kähler, Katharina C, Gutzmer, Ralf, Berking, Carola, Ugurel, Selma, Stadtler, Nadine, Sucker, Antje, Becker, Jürgen C, Livingstone, Elisabeth, Meier, Friedegund, Hassel, Jessica C, Schadendorf, Dirk, Hanoun, Maher, Heinzerling, Lucie, Zimmer, Lisa

Volltext

Human leukocyte antigen (HLA) class I expression on Hodgkin–Reed–Sternberg cells is an EBV‐independent major determinant of microenvironment composition in classic Hodgkin lymphoma... von Müller‐Meinhard, Berit, Seifert, Nicole, Grund, Johanna, Reinke, Sarah, Yalcin, Fatih, Kaul, Helen, Borchmann, Sven, Tresckow, Bastian, Borchmann, Peter, Plütschow, Annette, Richter, Julia, Engert, Andreas, Altenbuchinger, Michael, Bröckelmann, Paul J., Klapper, Wolfram

Volltext

Balancing risk and benefit in early-stage classical Hodgkin lymphoma von Bröckelmann, Paul J., Sasse, Stephanie, Engert, Andreas

Volltext

Moving things forward in Hodgkin lymphoma [version 1; peer review: 2 approved] von Bröckelmann, Paul J, Böll, Boris

Volltext

Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials von Sasse, Stephanie, Bröckelmann, Paul J, Goergen, Helen, Plütschow, Annette, Müller, Horst, Kreissl, Stefanie, Buerkle, Carolin, Borchmann, Sven, Fuchs, Michael, Borchmann, Peter, Diehl, Volker, Engert, Andreas

Volltext

Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Tri... von Bröckelmann, Paul J, Bühnen, Ina, Meissner, Julia, Trautmann-Grill, Karolin, Herhaus, Peter, Halbsguth, Teresa V, Schaub, Valdete, Kerkhoff, Andrea, Mathas, Stephan, Bormann, Matthias, Dickhut, Andreas, Kaul, Helen, Fuchs, Michael, Kobe, Carsten, Baues, Christian, Borchmann, Peter, Engert, Andreas, von Tresckow, Bastian

Volltext

Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity von Wang, Ying, Ertl, Carolin, Schmitt, Christina, Hammann, Linda, Kramer, Rafaela, Grabmaier, Ulrich, Schöberl, Florian, Anz, David, Piseddu, Ignazio, Pesch, Giulia, Vera, Julio, Froehlich, Waltraud, Weckbach, Ludwig, Tomsitz, Dirk, Loquai, Carmen, Zimmer, Lisa, Mangana, Johanna, Dummer, Reinhard, Gutzmer, Ralf, Klespe, Kai-Christian, Stege, Henner, Meiss, Frank, Thoms, Kai-Martin, Terheyden, Patrick, Bröckelmann, Paul J, Johnson, Douglas B, French, Lars E, Heinzerling, Lucie

Volltext

Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1 von Reinke, Sarah, Bröckelmann, Paul J., Iaccarino, Ingram, Garcia-Marquez, Maria, Borchmann, Sven, Jochims, Franziska, Kotrova, Michaela, Pal, Karol, Brüggemann, Monika, Hartmann, Elena, Sasse, Stephanie, Kobe, Carsten, Mathas, Stephan, Soekler, Martin, Keller, Ulrich, Bormann, Matthias, Zimmermann, Andreas, Richter, Julia, Fuchs, Michael, von Tresckow, Bastian, Borchmann, Peter, Schlößer, Hans, von Bergwelt-Baildon, Michael, Rosenwald, Andreas, Engert, Andreas, Klapper, Wolfram

Volltext